Xeris Biopharma Holdings Net Debt Growth & History (XERS)

Xeris Biopharma Holdings's net debt was $147.1M for fiscal 2025.

View full Xeris Biopharma Holdings company overview

Xeris Biopharma Holdings annual net debt history

Xeris Biopharma Holdings annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31$147.1M−$52.8M−26.41%
20242024-12-31$199.8M$38.1M+23.55%
20232023-12-31$161.7M$85.7M+112.56%
20222022-12-31$76.1M$55.3M+265.89%
20212021-12-31$20.8M−$28.6M−57.92%
20202020-12-31$49.4M

Xeris Biopharma Holdings net debt trends

Over the last five fiscal years, Xeris Biopharma Holdings's net debt increased from $49.4M to $147.1M, a change of $97.6M. The latest reported quarter, Q2 2026, shows $167.7M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Xeris Biopharma Holdings source filings ↗

Community posts

It’s quiet here.

No posts about XERS yet. Start the conversation.

Write the first post